Claraphi Advisory Network’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
$755K Buy
14,736
+4,105
+39% +$197K 0.3% 94
2022
Q3
$465K Sell
10,631
-10,070
-49% -$489K 0.25% 110
2022
Q2
$1.08M Buy
20,701
+234
+1% +$11.9K 0.38% 61
2022
Q1
$1.06M Sell
20,467
-526
-3% -$27.3K 0.31% 67
2021
Q4
$1.24M Buy
20,993
+6,056
+41% +$300K 0.43% 53
2021
Q3
$642K Buy
14,937
+575
+4% +$25.5K 0.23% 107
2021
Q2
$562K Buy
14,362
+133
+0.9% +$5.17K 0.17% 141
2021
Q1
$516K Sell
14,229
-5,564
-28% -$198K 0.14% 153
2020
Q4
$729K Sell
19,793
-13,187
-40% -$484K 0.2% 108
2020
Q3
$1.15M Buy
32,980
+20,270
+159% +$711K 0.42% 41
2020
Q2
$394K Sell
12,710
-306
-2% -$10.4K 0.17% 129
2020
Q1
$403K Buy
13,016
+633
+5% +$21.6K 0.19% 103
2019
Q4
$460K Sell
12,383
-1,881
-13% -$67K 0.28% 83
2019
Q3
$486K Buy
14,264
+214
+2% +$7.78K 0.29% 74
2019
Q2
$576K Buy
14,050
+1,019
+8% +$40.5K 0.34% 71
2019
Q1
$524K Sell
13,031
-337
-3% -$13.5K 0.33% 73
2018
Q4
$554K Sell
13,368
-10,752
-45% -$446K 0.42% 62
2018
Q3
$1.01M Sell
24,120
-787
-3% -$30.3K 0.56% 40
2018
Q2
$857K Buy
24,907
+986
+4% +$33.7K 0.55% 45
2018
Q1
$805K Buy
23,921
+4,929
+26% +$169K 0.57% 44
2017
Q4
$653K Buy
+18,992
New +$648K 0.51% 57

Other funds holding PFE

Claraphi Advisory Network's PFE Position: Q4 2022 in Review

Claraphi Advisory Network increased its Pfizer (PFE) stake by 39% in Q4 2022, buying an estimated $197K and bringing the position to 14,736 shares worth $755K. The position accounts for 0.3% of the portfolio, ranked #94.

Claraphi Advisory Network first reported a position in PFE in Q4 2017 and has held it in 21 quarters since. The position peaked at $1.24M in Q4 2021. 3,265 funds tracked by Wall St. Rank hold PFE as of Q4 2022.

  • Claraphi Advisory Network held 14,736 shares of Pfizer worth $755K as of Q4 2022.
  • Claraphi Advisory Network bought 4,105 Pfizer shares in Q4 2022, an estimated $197K.
  • Pfizer made up 0.3% of Claraphi Advisory Network's portfolio in Q4 2022, its #94 holding.
  • Claraphi Advisory Network first reported a position in Pfizer in Q4 2017 and has held it in 21 quarters since.
  • Claraphi Advisory Network's Pfizer position peaked at $1.24M in Q4 2021.
  • 3,265 funds tracked by Wall St. Rank held Pfizer as of Q4 2022.

Based on Claraphi Advisory Network's 13F filing for Q4 2022, filed 14 Feb 2023.